Background: Previous works indicated that the stress on the endoplasmic reticulum (ER) affected nonalcoholic fatty liver disease (NAFLD). However, there is no clear evident on the effect of the regulation of ER stress by angiotensin-converting enzyme 2 (ACE2) on the prevention of NAFLD. Methods: HepG2 cells were treated with thapsigargin (Tg) or palmitic acid (PA). We analysed ACE2 expression using Western-blotting analyses. ER stress-related proteins were detected in ACE2 knockout mice and Ad-ACE2-treated db/db mice by immunofluorescence or Western-blotting analyses. In ACE2-overexpression HepG2 cells, the triglyceride (TG), total cholesterol (TC), and glycogen content were detected by assay kits. Meanwhile, the expression of hepatic lipogenic proteins (ACCa, SREBP-1c, FAS, and LXRa), enzymes for gluconeogenesis (PEPCK, G6Pase, and IRS2), and IKK beta/NF kappa B/IRS1/Akt pathway were analysed by Western-blotting analyses. Results: ACE2 was significantly increased in Tg/PA-induced cultured hepatocytes. Additionally, ACE2 knockout mice displayed elevated levels of ER stress, while Ad-ACE2-treated db/db mice showed reduced ER stress in liver. Furthermore, activation of ACE2 can ameliorate ER stress, accompanied by decreased TG content, increased intracellular glycogen, and downregulated expression of hepatic lipogenic proteins and enzymes for gluconeogenesis in Tg/PA-induced hepatocytes. As a consequence of anti-ER stress, the activation of ACE2 led to improved glucose and lipid metabolism through the IKK beta/NF kappa B/IRS1/Akt pathway. Conclusions: This is the first time documented that ACE2 had a notable alleviating role in ER stress-induced hepatic steatosis and glucose metabolism via the IKK beta/NF kappa B/IRS1/Akt-mediated pathway. This study may further provide insight into a novel underlying mechanism and a strategy for treating NAFLD.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81561128015, 81471014, 81670774]; Natural Science Foundation of Beijing MunicipalityBeijing Natural Science Foundation [7162047]
第一作者机构:[1]Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing 100730, Peoples R China[2]Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China[3]Capital Med Univ, Beijing Tongren Hosp, Beijing Diabet Inst, Beijing, Peoples R China[4]Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA[5]Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD USA
共同第一作者:
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing 100730, Peoples R China[2]Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China[3]Capital Med Univ, Beijing Tongren Hosp, Beijing Diabet Inst, Beijing, Peoples R China[*1]Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
推荐引用方式(GB/T 7714):
Cao Xi,Song Li-Ni,Zhang Yi-Chen,et al.Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease[J].DIABETES-METABOLISM RESEARCH AND REVIEWS.2019,35(4):doi:10.1002/dmrr.3123.
APA:
Cao, Xi,Song, Li-Ni,Zhang, Yi-Chen,Li, Qi,Shi, Ting-Ting...&Yang, Jin-Kui.(2019).Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease.DIABETES-METABOLISM RESEARCH AND REVIEWS,35,(4)
MLA:
Cao, Xi,et al."Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease".DIABETES-METABOLISM RESEARCH AND REVIEWS 35..4(2019)